Vericel Corp Files 8-K: Director/Officer Changes & More
Ticker: VCEL · Form: 8-K · Filed: May 2, 2025 · CIK: 887359
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, financials
Related Tickers: Vcel
TL;DR
Vericel Corp 8-K: Director/officer changes, votes, and financials filed April 30.
AI Summary
Vericel Corporation filed an 8-K on May 2, 2025, reporting events as of April 30, 2025. The filing includes information regarding the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also covers the submission of matters to a vote of security holders and financial statements and exhibits.
Why It Matters
This 8-K filing indicates potential shifts in corporate leadership and governance at Vericel Corporation, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — This is a routine 8-K filing detailing corporate governance and financial events, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 001-35280 — SEC File Number (Identifies Vericel Corporation's filing with the SEC.)
- 94-3096597 — EIN (Employer Identification Number for Vericel Corporation.)
Key Players & Entities
- Vericel Corporation (company) — Registrant
- Michigan (jurisdiction) — State of incorporation
- 001-35280 (company) — Commission File Number
- 94-3096597 (company) — I.R.S. Employer Identification No.
- 64 Sidney Street, Cambridge, MA 02139 (location) — Principal executive offices address
- April 30, 2025 (date) — Date of earliest event reported
- May 2, 2025 (date) — Date of report
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, election of directors, and appointment of certain officers, along with details on compensatory arrangements, but specific names and details are not provided in this summary.
Were any matters submitted to a vote of security holders?
Yes, the filing explicitly states that matters were submitted to a vote of security holders.
What financial information is included in this filing?
The filing includes financial statements and exhibits.
What is the principal executive office address for Vericel Corporation?
The principal executive offices are located at 64 Sidney Street, Cambridge, MA 02139.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on April 30, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 2, 2025 regarding Vericel Corp (VCEL).